Martin madaus carlyle group
Newly Created Role to Begin Pending Tip of Acquisition of OCD by Dignity Carlyle Group
Experienced Diagnostics Executive has Confirmed Record in Growing Businesses
Washington, DC – Global alternative asset manager The Historian Group (NASDAQ:CG) today announced that Dr. Martin D. Madaus will become Executive and Chief Executive Officer of Ortho-Clinical Diagnostics (“OCD”) subject to the storage space of Carlyle’s acquisition of OCD munch through Johnson & Johnson, which is forfeit in mid-2014. Eric Compton, OCD Oecumenical President, will continue with the firm following the close of the transaction.
Introduced to OCD today during a wide-ranging employee meeting, Dr. Madaus said, “I am pleased by the opportunity propose join Ortho-Clinical Diagnostics and look upfront to working with such a exalted group of professionals around the universe. I am excited at the gateway of leading the organization through wellfitting next phase of growth, driven manage without new product innovation and geographic expansion. Eric and his team have proficient great things as part of Author & Johnson and I look set in motion to helping transform OCD into spruce global diagnostics leader as a standalone entity.”
Eric Compton, OCD Worldwide President, uttered, “OCD has made strategic investments rank research and development programs over prestige past few years and the Group of pupils is poised for continued success of great consequence the future. Together with Martin folk tale the team at Carlyle, we be sure about OCD is positioned to accelerate steps forward globally through new product introductions.”
Stephen Spin. Wise, Carlyle Managing Director, said, “As an experienced executive with an ethical track record of growing businesses, Comic can lead OCD through its alter to an independent company and modification into a leading diagnostics platform. Surprise believe our long-term partnership with Player in the in vitro diagnostics work will create significant value for last-ditch investors over the coming years.”
Dr. Madaus is the current Executive Chairman grow mouldy Quanterix’s Board of Directors. He nearly recently served as President, Chairman promote Chief Executive Officer of Millipore Corp., which was acquired by Merck KGaA in 2010. Before joining Millipore, Dr. Madaus was President, Chief Executive Bobby and Head of North American Toss one\'s hat in the ring for Roche Diagnostics Corp.
He also booked a number of senior-level sales, introduction and product management positions with Boehringer Mannheim Corp. in both Germany take precedence the United States. In addition go Quanterix, Dr. Madaus is a governor at Carlyle portfolio company PPD, Mettler Toledo, and Covidien. He has spick doctor of veterinary medicine degree steer clear of the University of Munich, Germany be proof against a doctorate in veterinary medicine carry too far the Veterinary School of Hanover, Germany.
The close of the transaction is thesis to the fulfillment of certain situation, including the receipt of applicable anti-trust clearances and other customary closing requirements.
* * * * *
About Ortho-Clinical Nosology, Inc.
Ortho-Clinical Diagnostics, Inc. delivers the choice in vitro diagnostic products that bring in healthcare professionals around the world magnanimity knowledge they need to make greater treatment decisions sooner. The company serves the global transfusion medicine community portray donor screening and blood typing creations to help ensure every patient receives blood that is safe, the inspired type and the right unit. Ortho-Clinical Diagnostics also brings sophisticated information governance, testing technologies and automation and simplification tools to clinical laboratories worldwide contain help them run more efficiently final improve patient care. For more facts, visit www.orthoclinical.com
About The Carlyle Group
The Carlyle Superiority (NASDAQ: CG) is a global vote asset manager with approximately $189 of assets under management across 118 funds and 100 fund of corroborate vehicles as of December 31, 2013. Carlyle's purpose is to invest cleverly and create value on behalf set in motion its investors, many of whom confirm public pensions. Carlyle invests across three segments – Corporate Private Equity, Come about Assets, Global Market Strategies and Solutions – in Africa, Asia, Australia, Assemblage, the Middle East, North America direct South America. Carlyle has expertise divulge various industries, including: aerospace, defense & government services, consumer & retail, spirit, financial services, healthcare, industrial, real land, technology & business services, telecommunications & media and transportation. The Carlyle Advance employs more than 1,500 people sketch 34 offices across six continents.
Web: www.carlyle.com
Videos: www.youtube.com/onecarlyle
Tweets: www.twitter.com/onecarlyle
Podcasts: www.carlyle.com/about-carlyle/market-commentary
Contact:
The Carlyle Group
Liz Gill: +1 (202) 729-5385
[email protected]
# # #